FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- PACE Financing Makes Progress but Still Encounters Opposition
- Grand View: Datacenter Cooling Market Worth $17.78B by 2024
- Idaho Opens First Solar Farm
- What You Need To Know About Green Insulation: Green Seal’s New Standard
- Obama Administration to Provide Up to $4.5 billion in Loan Guarantees for Electric Charging Stations
- Minnesota PUC Approves New Rate Structure, Size Cap for Solar Gardens
- Maine PUC Endorses Natural Gas Pipeline Expansion at Expense of Ratepayers
- Geothermal Heating and Cooling is Worth Another Look